ArticleApplied microscopy2026
Umbelliferone-induced recovery of postsynaptic density structure revealed by the reanalysis of public electron microscopy data.
Article in Applied microscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Public biological data repositories not only ensure research reproducibility and transparency but also enable new scientific discoveries that extend beyond the scope of original studies. A previously published study on umbelliferone (UMB) demonstrated recovery of synaptic vesicle architecture under scopolamine (SCO)-induced pathological conditions, and the corresponding high-resolution electron microscopy dataset was deposited in the Korea BioData Station (K-BDS, https://kbds.re.kr ), a national biological data platform.In this study, we reanalyzed this open dataset to investigate whether UMB also affects the postsynaptic density (PSD), a previously unexplored structural determinant of synaptic efficacy and plasticity. Using the original high-resolution transmission electron microscopy images, we performed secondary quantitative analyses focusing on PSD length, width, and ultrastructural features across experimental groups. Our reanalysis revealed that UMB treatment significantly increased PSD length and width compared with the SCO-treated group, indicating a structural restoration of impaired postsynaptic architecture. Notably, these PSD-level alterations were not described in the original publication, demonstrating that novel biological insights can be derived from existing data through purposeful reuse.Collectively, this study underscores the value of K-BDS as a national biological data platform that facilitates secondary discovery and advances data-driven neuroscience research without additional animal experimentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.